Cybin Inc./$CYBN
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX
About Cybin Inc.
Cybin Inc is a biopharmaceutical company involved in creating safe and effective therapeutics for patients to address a multitude of mental health issues. The Company is a clinical-stage neuropsychiatric company focused on advancing therapies, delivery mechanisms, novel compounds, and protocols as potential treatments for various psychiatric and neurological conditions. The Company is developing technologies and delivery systems aimed at improving the pharmacokinetics of its proprietary molecules while retaining the therapeutic benefit. These new molecules and delivery systems are expected to be studied through clinical trials to confirm safety and efficacy.
Ticker
$CYBN
Sector
Primary listing
AMEX
Employees
-
Headquarters
Toronto, Canada
Website
Cybin Inc. Metrics
BasicAdvanced
$147M
-
-$4.65
1.11
-
Price and volume
Market cap
$147M
Beta
1.11
52-week high
$9.83
52-week low
$4.81
Average daily volume
748K
Financial strength
Current ratio
9.871
Quick ratio
8.438
Long term debt to equity
29.323
Total debt to equity
29.323
Interest coverage (TTM)
-39.33%
Profitability
EBITDA (TTM)
-114.645
Management effectiveness
Return on assets (TTM)
-34.25%
Return on equity (TTM)
-54.31%
Valuation
Price to book
0.89
Price to tangible book (TTM)
1.59
Price to free cash flow (TTM)
-1.426
Free cash flow yield (TTM)
-70.14%
Free cash flow per share (TTM)
-4.103
Growth
Earnings per share change (TTM)
-3.19%
3-year earnings per share growth (CAGR)
-24.27%
Cybin Inc. News
AllArticlesVideos
Cybin Highlights Neuropsychiatry Platform and Upcoming Clinical Milestones
Business Wire3 weeks ago
CYBN Investors Have Opportunity to Join Cybin Inc. Fraud Investigation with the Schall Law Firm
Business Wire1 month ago
Cybin to Participate in TD Cowen's 5th Annual Novel Mechanisms in Neuropsychiatry & Epilepsy Summit
Business Wire1 month ago
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
Capital at risk
Upcoming events
No upcoming events
FAQs
What’s the current market cap for Cybin Inc. stock?
Cybin Inc. (CYBN) has a market cap of $147M as of October 14, 2025.
What is the P/E ratio for Cybin Inc. stock?
The price to earnings (P/E) ratio for Cybin Inc. (CYBN) stock is 0 as of October 14, 2025.
Does Cybin Inc. stock pay dividends?
No, Cybin Inc. (CYBN) stock does not pay dividends to its shareholders as of October 14, 2025.
When is the next Cybin Inc. dividend payment date?
Cybin Inc. (CYBN) stock does not pay dividends to its shareholders.
What is the beta indicator for Cybin Inc.?
Cybin Inc. (CYBN) has a beta rating of 1.11. This means that it is more volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 2 would indicate the stock moves twice as much as the market.